Kezar Life Sciences, Inc.
USD7.29
+0.00 (+0.00%)
CEO
Christopher J. Kirk
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.29
Prev. Close
$7.29
Day Low
$7.29
Day High
$7.29
52W Low
$3.53
52W High
$7.55
Market Cap
$0.05B
| 5,000 |
| $6.70 |
| 11 May 2026 | COOPER GRAHAM K | director | D-Return | Disposed | 5,000 | $4.46 |
| 11 May 2026 | COOPER GRAHAM K | director | D-Return | Disposed | 2,600 | $22.80 |
| 11 May 2026 | Garner Elizabeth | director | D-Return | Disposed | 3,500 | $26.40 |
| 11 May 2026 | Garner Elizabeth | director | D-Return | Disposed | 5,000 | $6.70 |
| 11 May 2026 | Garner Elizabeth | director | D-Return | Disposed | 5,000 | $4.46 |
| 11 May 2026 | Garner Elizabeth | director | D-Return | Disposed | 2,600 | $22.80 |
| 11 May 2026 | BERGER FRANKLIN M | director | U-Tender | Disposed | 89,069 | $6.96 |
| 11 May 2026 | BERGER FRANKLIN M | director | D-Return | Disposed | 3,500 | $26.40 |